Pages that link to "Q48414672"
Jump to navigation
Jump to search
The following pages link to Has the well gone dry? The First Cain Memorial Award Lecture (Q48414672):
Displaying 9 items.
- Phase I clinical trial of fludarabine phosphate (F-ara-AMP). (Q33411033) (← links)
- Effects of 2-chloroadenine substitution in DNA on restriction endonuclease cleavage reactions (Q35766988) (← links)
- Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine (Q36267473) (← links)
- Membrane transport and the antineoplastic action of nucleoside analogues (Q39697046) (← links)
- Fludarabine phosphate. A new anticancer drug with significant activity in patients with chronic lymphocytic leukemia and in patients with lymphoma (Q40397753) (← links)
- Synthesis of 5-chloroformycin A, 5-chloro-2'-deoxyformycin A and certain related 5,7-disubstituted 3-beta-D-ribofuranosylpyrazolo[4,3-d] pyrimidines from formycin A. (Q40560367) (← links)
- Lack of cross-resistance between cytosine arabinoside and a new halogenated nucleoside analogue, 2-bromo-2'-deoxyadenosine in human acute myeloid leukaemia cells (Q42216636) (← links)
- 2-Chloro-2'-deoxyadenosine monophosphate residues in DNA enhance susceptibility to 3'-->5' exonucleases (Q42829076) (← links)
- Phase II study of fludarabine phosphate in patients with advanced colorectal carcinoma (Q69036403) (← links)